Active Pharmacist Ward Integration Outperforms Education in Renal Prescribing
This stepwise Turkish study isolates the incremental value of real-time clinical pharmacist ward participation over passive physician education in reducing drug-related problems among patients with renal dysfunction.
Pharmacist interventions cut drug-related issues by 30% in renal patients.
Renal dysfunction complicates medication management, increasing the risk of drug-related problems (DRPs). Pharmacist interventions reduced DRPs by 30%, ensuring safer medication use in patients with renal dysfunction. The study supports integrating pharmacists in care teams to improve medication safety in patients with renal impairment. Clinical pharmacists significantly decrease drug-related problems in hospitalized patients with renal dysfunction.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Citation:Özmen Ö, Bektay MY, Karatoprak C, et al. Impact of clinical pharmacist interventions on drug-related problems in hospitalised patients with renal dysfunction: a quasi-experimental study. Scientific reports. 2026;16(1). doi:10.1038/s41598-026-51690-w
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.